IVZ
Loading…
PREV CLOSE OPEN DAY RANGE
Analyzing 0%
MASTER
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence
Data coverage

IVZ Stock AI Analysis

ESEN AI analysis of IVZ stock updated every 12 hours.

ESEN Institutional Analysis

IVZ Systematic Research

Invesco Ltd presents a distinctive profile within asset management, trading at 0.96x book value despite holding substantial net assets per share of $27.55. The systematic screening highlights significant operational headwinds, with revenue declining 14.48% year-over-year and negative profitability metrics across key measures: ROE at -0.51%, ROA at -0.23%, and a net margin of -7.8%. The current price of $29.60 positions the stock near the upper boundary of its 52-week range of $20.08–$31.02, following a modest 1-day gain of 0.61%.

The company's structural advantages include:

  • Moderate leverage profile with a debt-to-equity ratio of 0.77, providing flexibility relative to the sector's capital-intensive nature
  • Gross margin preservation at 66.03%, indicating pricing power despite revenue compression
  • Valuation discount to book value offering a potential margin of safety on tangible assets

Risk factors warrant examination. The operating margin of -14.46% and negative EPS of $0.16 reflect substantial profitability challenges, while the current ratio of 0.8 signals near-term liquidity constraints. The elevated beta of 1.6 amplifies volatility exposure during market downturns, a particular concern for financial services firms facing redemption pressures.

Relative to peers including TPG, Carlyle Group (CG), and Blue Owl Capital (OWL), Invesco operates within traditional asset management facing secular fee compression, contrasting with alternative asset managers experiencing inflows. The price-to-sales ratio of 2.48x reflects market skepticism regarding earnings normalization. The model indicates that systematic fundamental criteria flag operational execution as the critical variable determining whether the current valuation represents cyclical trough pricing or structural impairment.

Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.

Related Stocks
AAPL NVDA MSFT AMZN GOOGL META TSLA AVGO JPM V MA LLY UNH XOM JNJ WMT PG HD MRK COST BAC ABBV CRM CVX ORCL KO PEP AMD NFLX ADBE

Explore AI analysis for top stocks — Full Rankings · AI Screener · Earnings Calendar